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Summ a r y
Persons who have hypermethylation of one allele of MLH1 in somatic cells through-
out the body (a germ-line epimutation) have a predisposition for the development 
of cancer in a pattern typical of hereditary nonpolyposis colorectal cancer. By study-
ing the families of two such persons, we found evidence that the epimutation was 
transmitted from a mother to her son but was erased in his spermatozoa. The af-
fected maternal allele was inherited by three other siblings from these two families, 
but in those offspring the allele had reverted to the normal active state. These find-
ings demonstrate a novel pattern of inheritance of cancer susceptibility and are 
consistent with transgenerational epigenetic inheritance.
Hereditary nonpolyposis colorectal cancer results from germ-line sequence mutations in mismatch-repair genes, particularly MLH1 and MSH2. Somatic inactivation of the remaining normal allele by genetic or 
epigenetic events leads to the development of microsatellite instability in tumors of 
the colorectum or endometrium at a young age.1 Methylation of cytosines that pre-
cede a guanosine in the DNA sequence (the CpG dinucleotide) is a key epigenetic 
modification, and hypermethylation of gene promoters is associated with transcrip-
tional silencing.2 In sporadic colorectal cancer, methylation of both alleles of the 
promoter of MLH1 occurs as a somatic event early in tumorigenesis and is seen in 
approximately 15% of patients.3
Studies have shown that hypermethylation of MLH1 is not limited to neoplastic 
cells. Rather, in some persons, hypermethylation of a single allele of MLH1 origi-
nates in the germ line and is thus widespread in normal somatic cells.4-7 This phe-
nomenon of germ-line epimutation silences the affected allele in the absence of 
intragenic sequence mutations. Persons with a germ-line epimutation, like those 
with hereditary nonpolyposis colorectal cancer, have only one functional allele of 
the MLH1 gene from conception, and cancers typical of the hereditary nonpolypo-
sis colorectal cancer syndrome have developed in all such cases described to date.4-7 
Colorectal and other tumors in persons with MLH1 germ-line epimutations do not 
express the MLH1 protein and have microsatellite instability (the hallmark of failed 
mismatch-repair function), accompanied in some cases by somatic loss of the 
wild-type allele.4-7
Although germ-line sequence mutations are faithfully transmitted from one gen-
eration to the next in a mendelian pattern, epimutations do not involve changes in the 
DNA sequence and are relatively unstable, perhaps as a result of epigenetic reprogram-
ming, in primordial germ cells and gametes,8 in the male genome in the zygote,9,10 
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and in the preimplantation embryo.11 This pro-
cess removes and resets epigenetic marks between 
generations. Nevertheless, nonmendelian patterns 
of transgenerational epigenetic inheritance have 
been reported in mice.12-14 In the eight previously 
reported cases of germ-line MLH1 epimutation in 
humans, no intergenerational transmission was 
found, although in one patient the epimutation 
was reported in a low proportion of spermatozoa.4
Since the presence of an MLH1 epimutation in 
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Figure 1. Germ-Line Epimutation and Allelic Loss of Expression of MLH1 in Patients A and B.
Panel A shows a map of the CpG island encompassing the MLH1 and EPM2AIP promoters. The transcriptional start 
site is indicated by +1. Individual CpG doublets are depicted as circles. Horizontal bars show the regions amplified 
for combined bisulfite restriction analysis and bisulfite allelic sequencing. Primer positions are indicated by short 
arrows. Sites for restriction enzymes that exclusively cleave combined bisulfite restriction analysis amplicons from 
methylated templates are shown. Panel B shows bisulfite allelic sequencing of the C region of the MLH1 promoter 
in somatic tissues from Patient A and Patient B. Each horizontal line represents a single allele, and circles depict in­
dividual CpG dinucleotides as numbered, with black circles indicating methylated dinucleotides and white circles in­
dicating unmethylated dinucleotides. Single­nucleotide polymorphism (SNP) rs1800734 is indicated with G in orange 
and A in green. Panel C shows representative sequence­based fluorescent electropherograms showing the SNP within 
exon 8 of MLH1 in the genomic DN  (gDNA) and messenger RNA (mRNA) from peripheral­blood leukocytes of  
Patient A; gDNA shows heterozygosity (arrow), whereas transcription is restricted to the G allele. Panel D is a sche­
matic diagram of the effect of the germ­line epimutation on allelic activity of MLH1 in Patient A. Uniparental meth­
ylation of the promoter A allele (SNP rs1800734) causes allelic inactivation, so that only the allele with the G SNP  
at exon 8 (SNP rs1799977) is expressed (arrow).
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the germ line implies a potential for inheritance, 
we sought evidence for transmission between gen-
erations. In this study, we identified additional 
persons with germ-line MLH1 epimutations and 
in one family showed maternal transmission of 
the epimutation to her son but its erasure in his 
spermatozoa. Three other siblings from the two 
families we studied also inherited the affected 
maternal alleles, but in these cases the epimuta-
tion had reverted to the normal state, with con-
comitant allelic reactivation. These findings are 
consistent with germ-line transmission of a silent 
epigenetic state that confers disease susceptibil-
ity in humans.
Me thods
Patients and family members
Our study was approved by the ethics committee 
at St. Vincent’s Hospital in Sydney. Tissues were 
obtained with written informed consent from 
probands and family members at St. Vincent’s 
Hospital and Women’s and Children’s Hospital in 
Adelaide, Australia.
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Figure 2. Pedigrees of Patients A and B Showing Intergenerational Transmission of the MLH1 Epimutation  
and Haplotypes.
Panel A shows a map of SNPs within the MLH1 and EPM2AIP genes, used to determine inheritance patterns of the 
epimutant alleles and to analyze allelic expression. Panels B and C show pedigrees for Patient A and Patient B, with 
large black circles denoting Patient A and Patient B and with the current age of each family member given. Genera­
tions are listed I to III, and patients are identified by number. In Panels B and C, combined bisulfite restriction anal­
ysis of the C region of MLH1 (digested with MluI) is shown, with the lanes corresponding to data for family mem­
bers shown in the pedigrees directly above. Combined bisulfite restriction analysis was performed on DNA 
extracted from peripheral­blood leukocytes from all patients except family member II7­A and family member II8­A, 
from whom only hair­follicle DNA was available. Lane M indicates the pUC19/MspI DNA ladder, lane C− indicates 
DNA extracted from peripheral­blood leukocytes from a control with an unmethylated MLH1 promoter, and lane C+ 
indicates DNA extracted from the biallelically methylated RKO colorectal­carcinoma cell line (ATCC). Band sizes (in 
base pairs) are shown at the right. At the bottom of Panels B and C, haplotypes generated from informative SNPs 
are listed according to the key for each pedigree. Alleles associated with the epimutation are highlighted in yellow, 
and the presence of methylation (Me) is indicated. Maternally inherited alleles are shown in red, and paternally de­
rived alleles are shown in blue; black letters indicate unknown parental origin. Although the haplotypes associated 
with the epimutation were inherited by several children, only family member II6­A retained the epimutation.
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We selected 24 patients in whom colorectal or 
endometrial cancer had developed before the age 
of 50 years and who lacked deleterious germ-line 
sequence mutations in MSH2 or MLH1. In each 
case, the tumors had microsatellite instability, 
with complete loss of MLH1 protein expression 
and retention of MSH2. Additional tissues were 
collected from patients shown to carry an MLH1 
germ-line epimutation and from their first-degree 
relatives. The “swim-up” procedure was used to 
isolate motile spermatozoa.15 To remove contami-
nating somatic cells, spermatozoa that were used 
for DNA analyses were additionally sorted by flow 
cytometry (FACSVantage DiVa, Becton Dickin-
son).16 DNA was extracted from spermatozoa, 
hair follicles, and buccal mucosa with the use of 
QuickExtract solution (Epicentre Biotechnologies) 
and from peripheral-blood leukocytes with the 
use of phenol–chloroform.
Methylation Analyses
Methylation of the promoter of MLH1 (A and C re-
gions) and of the EPM2AIP promoter on the op-
posite strand was identified with the use of com-
bined bisulfite restriction analyses (Fig. 1A) and 
confirmed by allelic bisulfite sequencing.7
Quantitative real-time methylation-specific 
polymerase-chain-reaction (PCR) assays were per-
formed on bisulfite-treated DNA with the use of 
primers specific to methylated templates for the 
C region of MLH1 and the imprinted SNRPN gene.17 
Primers that amplify the control gene MyoD re-
gardless of its methylation status were used to 
normalize for DNA input. Real-time methylation-
specific PCR assays with iQ SYBR Green Super-
mix reagent were analyzed with the use of a real-
time PCR system (MyiQ, BioRad). Absolute values 
for experimental samples were calculated from 
the PCR cycle number at which the fluorescence 
crossed the threshold with the use of a standard 
curve. The percentage of methylated alleles in the 
C region of MLH1 and SNRPN was calculated 
against MyoD with reference to 100% in vitro 
methylated human DNA (Chemicon).18 All primer 
sequences are available on request.
Haplotyping
Single-nucleotide polymorphism (SNP) typing was 
performed by PCR amplification of constitution-
al DNA followed by restriction digestion or direct 
sequencing of the purified amplicons. Markers 
of sequence-tagged sites were typed by PCR am-
plification with the use of f luorescent-labeled 
primers,19 separated by capillary electrophoresis 
on an automated DNA sequencer, and sized with 
the use of LIZ markers (ABI 3700, Applied Bio-
systems).
Allelic Expression
For each patient or family member, heterozy-
gous polymorphisms within exons of MLH1 and 
EPM2AIP were used to identify the alleles being 
transcribed.20 RNA was extracted from periph-
eral-blood leukocytes, lymphoblastoid cells, and 
Figure 3 (facing page). Maternal Inheritance of the 
MLH1 Germ-Line Epimutation by Family Member II6-A 
and the Erasure of the Epimutation in His Spermatozoa.
Panel A shows methylation and monoallelic expression 
of MLH1 in the somatic tissues of a son of Patient A, 
family member II6­A. Bisulfite allelic sequencing of the 
C region of the MLH1 promoter in somatic tissues 
from family member II6­A appears at the top of the 
panel. Each horizontal line represents a single allele, 
and circles depict individual CpG dinucleotides, with 
black circles indicating methylated dinucleotides and 
white circles indicating unmethylated dinucleotides. 
family member II6­A is homozygous for the rs1800734 
SNP (indicated by green boxes). Sequence electrophe­
rograms show the exon 16 C→T SNP (arrow). The SNP 
is at nucleotide position 1890 of the MLH1 messenger 
RNA sequence (GenBank accession number NM000249) 
and does not confer any amino acid change. Family 
member II6­A and his father are heterozygous for this 
SNP. Family member II6­A expresses MLH1 from only 
the paternally derived (T) allele. Panel B shows erasure 
of the germ­line MLH1 epimutation in spermatozoa 
obtained from family member II6­A. At the top of the 
panel, the map shows the region of the MLH1 promot­
er amplified by real­time methylation­specific PCR. Be­
low the map, a graph shows the percentage of alleles 
methylated at either MLH1 or the differentially methyl­
ated region of the imprinted SNRPN gene, as deter­
mined by real­time methylation­specific PCR. SNRPN 
is an imprinted gene methylated specifically on the 
maternal allele; it is unmethylated in mature spermato­
zoa,21 providing a control for somatic contamination of 
the spermatozoa samples. As expected, SNRPN shows 
approximately 50% methylation in somatic DNA and 
negligible methylation in sperm DNA. In family mem­
ber II6­A, MLH1 shows 42% methylation in peripheral­
blood leukocytes (PBLs) but no methylation in sper­
matozoa. In the right portion of the panel, sequence 
electropherograms of the exon 16 C→T SNP from DNA 
and RNA in spermatozoa from family member II6­A 
show the presence of both MLH1 alleles in the sper­
matozoa DNA and biallelic expression in the RNA. 
Spermatozoa for the RNA analysis were subjected to 
the “swim­up” technique only and may contain a pro­
portion of somatic cells.
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spermatozoa with the use of Trizol reagent (Invi-
trogen), treated with DNaseI, and converted to 
complementary DNA (cDNA). Allelic expression 
was determined by sequencing cDNA at I219V SNP 
within exon 8 (rs1799977) and at polymorphisms 
within exon 16 and EPM2AIP.
R esult s
By studying the peripheral blood of 24 patients, 
we identified two unrelated women (Patient A and 
Patient B) who had the typical molecular and clin-
ical characteristics of persons with germ-line MLH1 
epimutations — namely, multiple MLH1-negative 
cancers of the colorectum and endometrium and 
hemiallelic methylation of MLH1 in all somatic 
cells. In both women, there was dense methylation 
of one allele of the MLH1 and EPM2AIP promoters 
in somatic cells from the three embryonic germ 
layers (Fig. 1B, and Fig. 1A of the Supplementary 
Appendix, available with the full text of this ar-
ticle at www.nejm.org). Both women had meta-
chronous carcinomas that had microsatellite in-
stability and lacked MLH1 expression. (Patient 
A received a diagnosis of cancer of the endometri-
um at the age of 45 years, of the colon at 59 years, 
−127
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and of the rectum at 60 years; Patient B received 
a diagnosis of cancer of the colon at 41 years and 
of the rectum at 45 years.) Patient A was hetero-
zygous for a SNP (rs1800734) within the MLH1 
promoter, with methylation confined to the A al-
lele. In both Patient A and Patient B, the methyl-
ated allele was transcriptionally silent, as evi-
denced by monoallelic expression of MLH1 and 
EPM2AIP transcripts in their messenger RNA 
(mRNA) (Fig. 1C and 1D, and Fig. 1B of the Sup-
plementary Appendix).
To identify MLH1 epimutations within fami-
lies of the probands, combined bisulfite restric-
tion analysis was performed on constitutional 
DNA from nine first-degree relatives, none of 
whom had a history of cancer (Fig. 2B and 2C). 
Partial methylation of MLH1 was found in one of 
Patient A’s four sons (family member II6-A) (Fig. 
2C). Methylation of the A allele (SNP rs1800734) 
on approximately 50% of chromosomes was con-
firmed by bisulfite sequencing (Fig. 3A). We iden-
tified an expressible C→T SNP within MLH1 exon 
16 in family member II6-A, which was used to 
demonstrate that he was transcribing RNA only 
from the MLH1 allele inherited from his father 
(Fig. 3A). These data are consistent with trans-
mission of the MLH1 epimutation from Patient A 
to her son.
To ascertain the possibility of transmission 
of the MLH1 epimutation from family member 
II6-A to his offspring, we studied the level of al-
lelic methylation in his pure motile spermatozoa 
with the use of a sensitive quantitative real-time 
methylation-specific PCR assay within the C re-
gion of MLH1 (Fig. 1A). In DNA from peripheral-
blood leukocytes obtained from family mem-
ber II6-A, approximately half of the MLH1 alleles 
(mean ±SD, 42.0±4.6%) were methylated. In con-
trast, his sperm had no trace of MLH1 methyla-
tion, despite containing equal proportions of al-
leles derived from his mother and father (Fig. 3B). 
Furthermore, analysis of the RNA in his sperm 
at the MLH1 exon 16 C→T SNP showed reactiva-
tion of the maternally derived MLH1 allele (Fig. 
3B). These results indicate reversion of the MLH1 
epimutation to normality during spermatogene-
sis, suggesting a negligible risk of transmission 
from family member II6-A (Fig. 4).
To investigate allelic inheritance patterns and 
the possibility that the epimutations were caused 
by alterations in the DNA strand carrying the 
allele that could influence methylation of the 
allele (in cis defects), we used SNPs within MLH1, 
EPM2AIP, and flanking sequence-tagged site mark-
ers to construct a haplotype map of a region of 
approximately 8 Mb around MLH1 for all mem-
bers of both families (Fig. 2B and 2C, and Fig. 
2 of the Supplementary Appendix). Patient A, her 
sister (family member I1-A), and three of her four 
sons (family members II5-A, II6-A, and II7-A) all 
shared a haplotype in this region, even though 
MLH1 was methylated only in Patient A and her 
son (family member II6-A). In the case of Patient 
B, haplotype and expression analysis (Fig. 2B, and 
Fig. 1 of the Supplementary Appendix) confirmed 
that the MLH1 epimutation resided on her ma-
ternally derived allele. This is likely to have arisen 
spontaneously, since we found no evidence of 
methylation in her mother (Fig. 2B). Notably, the 
haplotype in Patient B differed from the one on 
which the epimutation occurred in Patient A’s 
family. Patient B transmitted the haplotype to 
one of her two sons (family member III2-B), but 
there was no evidence of MLH1 methylation in 
his case (Fig. 2B). For both family member II5-A 
and family member III2-B, absence of methyla-
tion from their respective maternal alleles corre-
lated with biallelic expression from the MLH1 locus 
(Fig. 3 of the Supplementary Appendix), indicating 
reversion of the epimutation in these family mem-
bers or in their mothers’ germ cells. No recombi-
nations were observed in the vicinity of MLH1, 
indicating that the affected alleles were identical 
in family members bearing the epimutation and 
in those in whom it had reverted (Fig. 2 of the 
Supplementary Appendix).
Epimutations are meiotically reversible and 
often show somatic mosaicism. We therefore con-
sidered whether some family members had low 
levels of allelic MLH1 methylation, suggesting in-
complete somatic erasure of an epimutation, or 
a susceptibility of the allele to subsequent somatic 
methylation. With the use of real-time methyla-
tion-specific PCR, we found no evidence of allelic 
mosaicism for MLH1 methylation in any patient in 
our study, except those with epimutations (38±9% 
for Patient B, 42±7% for Patient A, and 42±4.6% 
for family member II6-A).
Discussion
We have found evidence of germ-line epimuta-
tion of MLH1 in a woman with cancer and in her 
son (Fig. 4), which supports the concept of trans-
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Figure 4. Schematic Representation of Inheritance of MLH1 Alleles in Three Sons of Patient A.
The diagram depicts MLH1 alleles within the nucleus of somatic cells and sperm, with pink representing maternal 
origin and blue representing paternal origin. Active transcription is indicated by an arrow, and the RNA transcripts 
from the alleles are shown within cytoplasm. In the mother, one allele was methylated in the promoter (red band) 
and therefore not transcribed; only RNA from her yellow allele was expressed. In her second son (family member 
II6­A), the maternally inherited allele (pink, red band) was silent, and the paternal allele (pale blue) was expressed. 
Haploid DNA within spermatozoa from the son contained alleles from both the father and mother, and both were 
transcribed. There was no evidence of methylation of either allele. The first and third sons (family members II5­A 
and II7­A) also inherited the affected maternal allele, but in these offspring methylation had been erased and bial­
lelic expression of MLH1 was found, indicating that the epimutation was reversed to the normal state. This model 
shows transgenerational inheritance of an epigenetically mutated tumor­suppresso  gene and subsequent r versal 
of the epimutation within spermatozoa.
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generational epigenetic inheritance. The MLH1 
epimutation that predisposed the mother to mul-
tiple tumors with microsatellite instability has 
increased the risk of cancer in her son (family 
member II6-A).
The findings from the two families in this 
study, as well as previous studies, offer insights 
into the pattern of inheritance of germ-line epi-
mutations. With reference to the parent of ori-
gin, the mother of family member II6-A, like the 
mothers of two patients with MLH1 epimutations 
reported previously, had cancer in a pattern typi-
cal of hereditary nonpolyposis colorectal cancer.6 
Furthermore, in two other cases in which germ-
line epimutations were shown to arise spontane-
ously (Patient B and a patient whose case was 
reported previously7 ), the methylated allele was 
maternally derived. Taken together, these data 
raise the possibility that epigenetic errors may 
arise more frequently during oogenesis or are more 
likely to be maintained during this process. Our 
finding of erasure of the epimutation during 
spermatogenesis in family member II6-A is con-
sistent with this hypothesis. However, paternal 
inheritance cannot be excluded, given our previ-
ous finding of low-level MLH1 methylation in 
sperm of an affected person.6
Another characteristic of the inheritance pat-
tern in the families in this study is that four 
sons inherited their mother’s MLH1 haplotype, 
yet in three of the sons, the maternally derived 
allele had undergone demethylation and tran-
scriptional reactivation. It appears that the nor-
mal process of gametogenesis allowed correction 
of the MLH1 epimutation, perhaps contempo-
raneously with erasure of parent-specific meth-
ylation of imprinted genes in primordial germ 
cells.11 If so, then transmission of an epimuta-
tion to family member II6-A must reflect resis-
tance to reprogramming, either through incom-
plete erasure or by retention of an epigenetic 
memory. Although at present we have limited in-
formation, the overall cancer risk for families with 
germ-line MLH1 epimutations appears to be lower 
than for those with germ-line sequence muta-
tions.
An alternative explanation for our findings is 
that epimutations are not inherited per se. Rather, 
they are erased in gametogenesis but reestab-
lished in successive generations because of cis-
acting or even trans-acting genetic factors that 
increase susceptibility to MLH1 epimutations.21,22 
Examples of epigenetic silencing that are driven 
by genetic events in cis include deletion of im-
print-control centers in imprinted disorders23 and 
expansion of triplet repeats within the FMR1 pro-
moter in the fragile X syndrome.24 Such a mecha-
nism may also explain the recently reported strong-
ly heritable pattern of epimutation in MSH2,25 
since the methylation state segregated faithfully 
with the genetic haplotype. In contrast, in the two 
families described in our study, we found no 
evidence of a fully penetrant in cis defect. Rather, 
they showed epimutations that were meiotically 
reversible and transmitted in a nonmendelian 
fashion. A simple explanation for this pattern is 
that epimutations can occur on any haplotype, and 
although they usually are cleared in the germ 
line, they may be retained at low but uncertain 
frequency.
Regardless of uncertainties about patterns, 
frequencies, and mechanisms of inheritance, 
offspring of patients with MLH1 epimutations 
must be regarded as being at risk for cancer until 
proven otherwise. The broader implication of this 
study is that disease states in humans may be the 
consequence of nonmendelian inheritance of epi-
genetic changes in one or more genes.
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